Cas:867165-11-5 3-Cyclobutyl-1-iodoimidazo[1,5-a]pyrazin-8-amine manufacturer & supplier

Chemical Name:3-Cyclobutyl-1-iodoimidazo[1,5-a]pyrazin-8-amine

CAS.NO:867165-11-5

Synonyms:s14-0270

Molecular Formula:C₁₀H₁₁IN₄

Molecular Weight:314.12600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:56.94000

Exact Mass:314.00300

LogP:2.11370

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like s14-0270 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,s14-0270 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,s14-0270 Use and application,s14-0270 technical grade,usp/ep/jp grade.

Related News: McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. p-nitrophenyl β-D-galactopyranosyl-(1-)6)-β-D-glucopyranoside manufacturers The European Medicines Agency on Friday rejected Kyowa Kirin’s Parkinson’s disease drug Nouryant (istradefylline), which the US FDA approved in 2019 under the brand name Nourianz. 5-chloro-N-(1-methoxy-3-(4-(2-oxopyridin-1(2H)-yl)benzamido)propan-2-yl)thiophene-2-carboxamide suppliers The CDC’s Advisory Committee on Immunization Practices (ACIP) decision on Thursday came after an hours-long discussion over a handful of Guillain-Barré syndrome (GBS) cases reported after J&J’s jab. The independent group of experts were also tasked with reviewing the need for booster shots, specifically for people with compromised immune systems. L-Aspartic acid, L-lysyl-L-valyl-L-threonyl-L-alanyl-L-phenylalanyl-L-leucyl- vendor & factory.